"Hi Bruce" Bruce? Bruce K. Patterson

New Post Public Reply Private Reply Replies (0) Message Board
smurph CDiddy #92929
864
"Hi Bruce"
Bruce?
Bruce K. Patterson MD
@brucep13
"IncellDx didn’t do any RO for the combination trial (BLA) and only the last third of the mono trial nor did we share any protocols. Last we use labeled PRO140 in our RO assay so blaming us is like saying the drug doesn’t bind to CCR5. So this is a lie!

Quote Tweet
opportoni
@opportoni
· May 30
Replying to @Mateo3032 and @RebeccaHUMBL
"Does @brucep13 know you use his picture to advertise the company that blamed him and his RO test of being responsible for the RTF letter they received for their HIV BLA? $CYDY
Replying to
@brucep13

"So what did you and the other IncellDX board member do to receive the shares?
https://twitter.com/brucep13/status/1400901208269750272
************************
Related?
"So the cat is out of the bag on the second receptor we have been targeting on #longcovid and #longhaulers for last several months.
"FRACTALKINE
Some of you correctly identified this in my previous post! Nice work!

"In addition, we identified significant reductions in the concentrations of fractalkine (CX3CL1) and monokine-induced-by-IFN-γ (MIG; CXCL9) along with increases in the concentrations of eotaxin 2 (CCL24) in #MECFS patients."

"A 30-year-old woman from the Greater Copenhagen region has become the first person in Denmark to receive compensation for side effects caused by Covid-19 vaccination.
https://twitter.com/YoDoctorYo/status/1400901...fsrc=email


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Transforming Healthcare Marketing: Salubrum's AI Innovation

Updated Category News Views 303

Innovating Healthcare Marketing with AI In today's rapidly evolving healthcare landscape, Salubrum, a cutting-edge vertical artificial intelligence (AI) company, has emerged as a pivotal player in reshaping the way healthcare brands connect with patients. By introducing an innovative commercialization engine, Salubrum has positioned itself at the forefront of healthcare...

Continue Reading
Evolution Petroleum Sets Upcoming Fiscal Q1 2025 Earnings Call

Updated Category News Views 81

Evolution Petroleum Schedules Fiscal First Quarter 2025 Earnings Release Evolution Petroleum Corporation (NYSE: EPM) has announced its upcoming plans regarding the financial results for the first quarter of fiscal 2025. The organization dedicated to providing substantial shareholder returns is set to unveil its operational and financial performance on a scheduled date...

Continue Reading
Collaboration Promotes Lifesaving Emergency Preparedness Nationwide

Updated Category News Views 152

Enhancing Emergency Response Preparedness Through Collaboration The American College of Surgeons (ACS) has teamed up with Lifesaving Technologies to create a significant nationwide initiative aimed at improving emergency response preparedness. This collaboration focuses on expanding access to critical lifesaving equipment and training, empowering communities to respond...

Continue Reading
Exploring VanillaSoft's New Voice Transcription Tool

Updated Category News Views 117

VanillaSoft Revolutionizes Sales Engagement with Voice Transcription Today, businesses are faced with the challenge of managing high call volumes while maintaining efficiency in tracking and analyzing call progress and quality. For a company like VanillaSoft, a frontrunner in sales engagement technology, addressing these issues is crucial. Recently, VanillaSoft unveiled a...

Continue Reading
StepStone Group Successfully Raises Over $700 Million for New Fund

Updated Category News Views 252

StepStone Group's Capital Commitment Success StepStone Group Inc. (Nasdaq: STEP), a renowned firm in the private markets investment arena, recently achieved a significant milestone by raising $705 million for its Tactical Growth Fund IV (STGF IV). This fund focuses on strategic opportunities within the growth equity market, backed by robust support from various investors....

Continue Reading